Melanotan I (Afamelanotide)
The only melanotan with FDA approval, cleared as Scenesse in 2019 for a rare disorder…
The read
What people observed
Every report answers on a 1–5 scale. This is the whole distribution, never an average pretending to be one number, though the average is beside it.
1 · no effect
2
2 · barely
2
3 · modest
4
4 · clearly worked
4
5 · textbook
2
3.1/5
Average reported outcome
79%
Would run it again
14
Reports filed · directional
What it did, and what else showed up
Counts across this compound's reports, never an average. One report can select several answers.
Reported positive outcomes
better sleep
3
faster recovery
3
mood / focus
3
injury healing
3
cardiovascular / circulation
3
fat loss
2
appetite suppression
2
cognition
2
more energy
1
joint / tendon relief
1
skin / hair
1
libido
1
better bloodwork
1
Reported side effects
Kept separate from positive outcomes on purpose.
headache
5
injection-site irritation
4
GI / nausea
3
none / clean
2
heart rate
2
sleep disruption
2
fatigue
1
mood / anxiety
1
appetite change
1
How it was run
What people brought it in for, and how long they stayed on it. Intent, not a result or a treatment claim.
What people were researching
body composition
2
blood sugar / metabolic
1
libido / sexual function
1
immune / inflammation
1
How long they ran it
1 wk
4
2 wk
2
4 wk
3
6 wk
2
8 wk
2
12 wk
1
Anecdote, never medical advice.
These are anonymous personal reports on an experimental research compound, not clinical evidence, and they never set the grade. Talk to a licensed clinician before you start, stop, or change a dose.